INTRODUCTION
Our research has focused on factors affecting cellular sensitivity of solid tumors to anticancer agents, and investigation of promising molecular targets for cancer treatment (1, 2) . Among many drugs, cis-diamminechloroplatinum (II) (cisplatin) plays a crucial role in the treatment of various solid tumors (3, 4) . Cisplatin has been shown to form a cross-link between adjacent purines in genomic DNA, and can cause DNA-damaging signals to induce apoptosis (1, 2) . Cisplatin treatment also induces oxidative and endoplasmic reticulum stresses (5) . Thus, the nature of cellular sensitivity to cisplatin is highly complex.
The development of cisplatin resistance is a major clinical limitation in cancer chemotherapy. Cisplatin resistance is influenced by many factors, which affect intracellular drug accumulation (6) (7) (8) , increased activity of intracellular thiol production (9, 10) and DNA repair (11, 12) .
However, little is known about the molecular mechanisms involved in drug resistance.
Cellular factors involved in transcription
contribute to the induction of apoptosis, or transient or acquired resistance. We have tried to identify the cisplatin-inducible transcription factors and transcription-related factors which are highly expressed in drug-resistant cells (1, 2, 13) . We have previously shown that expression of activating transcription factor 4 (ATF4) is inducible by cisplatin treatment, and is high in cisplatin-resistant cells (14) . The cellular level of ATF4 expression correlates with cisplatin sensitivity in human lung cancer cell lines. DNA microarray analysis has revealed that ATF4 regulates genes involved in glutathione biosynthesis and conjugation (15) .
Interestingly, we have found that ATF4 gene expression is regulated by the circadian transcription factor Clock, which is also overexpressed in cisplatin-resistant cells (16) .
It has recently been shown that histones are periodically acetylated (17) and that Clock is a member of the histone acetyltransferases (18) . Clock seems to have a highly specific emzymatic activity and acetylates histone 3 and histone 4 (19) . These results can open new aspect for cisplatin resistance.
Nissui Seiyaku (Tokyo, Japan) and contained 10% fetal bovine serum. The cisplatin-resistant KB/CP4 and P/CDP6 cells were derived from KB and PC3 cells as described previously (13) , and found to be 23-63-fold more resistant to cisplatin than their parental cells (6) . Eleven lung cancer cell lines were cultured as described previously (14) . Cell lines were maintained in a 5% CO 2 atmosphere at 37°C.
Antibodies and drugs.
Antibodies against c-Myc (sc-764), 
Western blot analysis.
Preparation of whole-cell lysates and whole-nuclear lysates have been described previously (16, 22) . Briefly, to prepare whole-nuclear lysates, isolated nuclei were directly sonicated for 10 s. The remaining cells were seeded in 100 mm dishes with 10 ml culture medium and harvested after 96 h culture for Western blotting, as described above.
Chromatin immunoprecipitation assay (ChIP).
The ChIP assay was performed as described previously (16, 22) . Briefly, 
Cytotoxicity assay.
For the colony-formation assay, days, the number of colonies was counted.
For correlation analysis, we calculated 50% inhibitory concentration (IC ) from the concentration-response curves.
50
RNA isolation.
Total RNA was extracted using Qiagen™ RNeasy Mini Kits (Qiagen, Valencia, CA)
following the RNeasy mini protocols for isolation from animal cells (I. spin protocol).
RNA quality and integrity were determined using the Eukaryote Total RNA Nano 6000 assay (Agilent RNA 6000 Nano LabChip Kit)
on the Agilent Technologies 2100
Bioanalyzer and quantified by measuring A260nm on a UV/Vis spectrophotometer (ND-1000, NanoDrop Technologies,
Rockland, DE).
Microarray studies and data analysis. 
Statistical analysis.
Expression levels of protein assayed by western blotting were assessed numerically with the NIH image program (NIH, Bethesda, MD). The Pearson correlation was used for statistical analysis, and significance was set at the 5% level. (Fig. 7C ).
RESULTS

Tip60 is overexpressed in cisplatin-
Cellular expression of Tip60 correlates with cisplatin sensitivity
We examined the correlation between Tip60 expression and cisplatin sensitivity in 11 lung cancer cell lines (Fig. 8) . Expression of β-actin was also examined as a control (Fig. 8A) , because β-actin expression in cisplatin-resistant cells is almost similar to that in parental cells (Fig. 1 ). Tip60 expression significantly correlated with cisplatin sensitivity (Fig. 8B) , and Clock expression (Fig. 8C) . We have previously
shown that Clock expression correlated with cisplatin sensitivity (16) . (Fig. 9A) . Further, the expression of these genes was significantly upregulated in cisplatin-resistant cells (Fig. 9B) . We found that both H3K14 and H4K16 were highly acetylated in cisplatin-resistant cells (Fig. 5) . It has been shown that Clock can acetylate H3K14 well (19) , and that Tip60 acetylates H2A and H4 (23, 29), which indicates that H4K16 may be catalyzed by Tip60. Our results using siRNA for Clock and Tip60 are consistent with those in previous studies (Fig. 6 ). The acetylation of H3K14 has been shown to be involved in transcriptional activation (19) . It has been
DISCUSSION
shown that the acetylation of H4K16 may contribute to the decondensation of chromatin (30). As shown in Fig. 7 , the ChIP Silencing Clock and Tip60 reduces histone acetylation. PC3 and PC/DP6 cells were transfected with control siRNA (100 pmol), Clock siRNA (100 pmol) and Tip60 siRNA (100 pmol).
Whole-nuclear lysates (50 μg for Clock and Tip60) and whole-cell extracts (25 μg for H3K9, H3K14, and 50 μg for H2AK5, H4K16) were subjected to SDS-PAGE, and Western blotting was performed with the indicated antibodies. Relative intensity is shown under each blot. 
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